Alcat Based Elimination Diet for the Treatment of Irritable Bowel Syndrome; a Randomized Double Blind Sham Control Trial
NCT05616429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2023-05-23
Summary
Irritable bowel syndrome (IBS) is the most common GI condition with global prevalence ranging between 10-20%. Although the exact cause is not known there are increasing insights concerning the possible multifactorial etiology including low grade inflammation, neuromodulation, dysbiosis, impaired integrity of the intestinal barrier and more.
Currently, it is believed that changes in the microbiota may activate mucosal innate immune responses, resulting in increased epithelial permeability, activated nociceptive sensory pathways, and dysregulation of the enteric nervous system.
Nearly two thirds of patients with IBS perceive their GI symptoms to be food related, hence, food intolerance may be important factor in the pathogenesis. Diet is a part of IBS treatment but adherence, on the one hand, and restriction, on the other, remain a major problem. \[Chey WD, Am J Gastroenterol,2016\].
Confocal laser endomicroscopy (CLE) is a technique that permits real-time detection and quantification of changes in intestinal tissues and cells, including increases in intraepithelial lymphocytes and fluid extravasation through epithelial leaks.
Based on CLE analysis of IBS patients with a suspected food intolerance, exposure to candidate food antigens caused immediate breaks, increased intervillous spaces, and increased IELs in the intestinal mucosa. These changes are associated with patient responses to exclusion diets. \[Fritscher-Ravens A et al, Gastroenterology. 2019, Gastroenterology. 2014\] This technic, also efficient according to former studies, is costly and invasive.
The Alcat Test is a lab based immune stimulation test in which a patient's WBC's (white blood cell) are challenged with various substances including foods, additives, colorings, chemicals, medicinal herbs, functional foods, molds and pharmaceutical compounds. The Alcat Test objectively classifies a patient's response to each test substance as reactive, borderline or non-reactive. Based on these classifications, a customized elimination/rotation diet may be designed.
Conditions
- IBS - Irritable Bowel Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Alcat based personal diet
Alcat based personalized diet with dietician supervision and follow-up + usual care
- DIETARY_SUPPLEMENT
-
Standard balanced diet
"Sham" standard balanced diet with dietician supervision and follow up + usual care.
- OTHER
-
usual care
usual care
Sponsors & Collaborators
-
Cell science systems
collaborator UNKNOWN -
Sheba Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2023-05-15
- Completion
- 2023-05-15
Countries
- Israel
Study Locations
More Related Trials
-
Elemental Diet and Gut Microbiome
NCT05978973 ·Status: COMPLETED ·Phase: NA
-
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
NCT06668922 ·Status: RECRUITING ·Phase: NA
-
FODMAP Reintroduction in Irritable Bowel Syndrome
NCT03245645 ·Status: COMPLETED ·Phase: NA
-
The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome
NCT02327780 ·Status: UNKNOWN ·Phase: NA
-
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
NCT00130741 ·Status: COMPLETED ·Phase: PHASE1
-
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
NCT05985018 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome
NCT07039747 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of FODMAPs in Patients With Irritable Bowel Syndrome
NCT05182593 ·Status: COMPLETED ·Phase: NA
-
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
NCT05016024 ·Status: COMPLETED ·Phase: NA
-
Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
NCT01886781 ·Status: COMPLETED ·Phase: PHASE4
-
One Year Home Monitoring and Treatment of IBS Patients
NCT03586622 ·Status: UNKNOWN ·Phase: NA
-
Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue
NCT05124262 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome
NCT00786123 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204 ·Status: UNKNOWN ·Phase: NA
-
Inuline Supplement in Patients With Irritable Bowel Syndrome
NCT03174561 ·Status: UNKNOWN ·Phase: NA
-
Dose-dependent FODMAP Reintroduction in IBS
NCT05808023 ·Status: COMPLETED ·Phase: NA
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
NCT01854060 ·Status: COMPLETED
-
Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome
NCT01624610 ·Status: COMPLETED ·Phase: NA
-
Treatment Efficacy of Low FODMAP Versus Low Lactose Diet in IBS Patients
NCT04543474 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome
NCT04542018 ·Status: COMPLETED ·Phase: NA
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA